![](/images/lcrn/west-midlands/HPMA%20Award.png)
Network's fitness platform is a winner
22 October 2021
#DoingOurBit fitness platform for NHS staff wins prestigious award
22 October 2021
#DoingOurBit fitness platform for NHS staff wins prestigious award
09 September 2021
Each year we make funding available for Improvement and Innovation ideas that will benefit the region's experience of, and access to, high quality research
20 August 2021
Lifesaving equipment donated by CRN WM to local football club
05 August 2021
The Respiratory Strategies in COVID-19; CPAP, High-flow, and Standard Care (RECOVERY-RS) trial has demonstrated that treating hospitalised COVID-19 patients who have acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation. Preliminary data from the trial also suggest that the routine use of high flow nasal oxygenation (HFNO), which can consume large amounts of oxygen, should be reconsidered as it did not improve outcomes for COVID-19 patients compared with conventional oxygen therapy. RECOVERY-RS, led by the University of Warwick and Queen’s University Belfast, is the world’s largest non-invasive respiratory support trial for COVID-19 - with over 1200 participants taking part across 48 UK hospitals. The multi-centre, adaptive, randomised controlled trial compared the use of CPAP (oxygen and positive pressure delivered via a tightly fitting mask), with HFNO (high pressure oxygen delivered up the nose), against standard care (standard oxygen therapy). All three interventions are commonly used to treat COVID-19 patients before they are moved onto invasive ventilation in a critical care bed, but it was not known which, if any, resulted in better outcomes.
03 August 2021
Extensive real-world data shows vaccines are safe and highly effective for pregnant women New government-funded clinical trial investigating best COVID-19 vaccine dose interval for pregnant women launched in England Research shows pregnant women more likely to become seriously ill from COVID-19 and 98% of those in hospital due to COVID-19 are unvaccinated
08 July 2021
The Network is delighted to announce it has appointed two new Deputy Clinical Directors (DCDs).
06 July 2021
The latest National Institute for Health Research (NIHR) Clinical Research Network (CRN) annual statistics show the extraordinary impact the organisation made in delivering vital clinical research during the 2020/21 pandemic.
20 May 2021
Celebrating International Clinical Trials Day 2021 - you have the power to change lives
19 May 2021
Volunteers from region will soon be able to receive a third ‘booster’ COVID-19 vaccine through a new clinical trial launching this week, the Health Secretary has announced.
26 April 2021
Volunteers from the West Midlands are being asked to sign up to the latest COVID-19 vaccine study to be rolled out across the UK.
14 April 2021
Researchers running the Com-Cov study investigating alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have announced a new study in Birmingham now including the Moderna and Novavax vaccines.
08 April 2021
The PRINCIPLE study is investigating several potential COVID-19 treatments which may help people to recover more quickly at home
15 March 2021
Milestone in Covid-19 research reached
09 February 2021
NHS hospitals, GPs and care homes in the West Midlands have played a vital role in delivering studies at pace and scale, enabling patients to benefit from the latest treatments for Covid-19 - in addition to helping tens of thousands of people gain early access to potential vaccines through trials running across the region.
04 February 2021
The National Institute for Health Research (NIHR)-supported study, which will be run at University Hospitals Birmingham NHS Foundation Trust, will determine the effects of using a different vaccine for the second dose to the first dose, in addition to two different intervals between doses.
29 January 2021
The Novavax study is the largest ever double blind, placebo-controlled trial to be undertaken in the UK. It recruited over 15,000 participants from 35 research UK sites in just over two months, including at Cheadle Hospital, part of Midlands Partnership NHS Foundation Trust.
18 December 2020
CRN West Midllands has published what it believes the largest and first cross-sectional survey in the UK to examine the various factors influencing the uptake of a potential approved COVID-19 vaccine.
16 December 2020
The new vaccine candidate - pioneered by Global biotech company Valneva and developed in Livingston, West Lothian - will be tested on 150 participants.
16 December 2020
NHS hospitals, GPs and care homes in the West Midlands have played a vital role in delivering studies at pace and scale, enabling patients to benefit from the latest treatments for Covid-19 - in addition to helping tens of thousands of people gain early access to potential vaccines through trials running across the region.
18 November 2020
CRN WM has been shortlisted despite the tough competition from over 1000 entries. They have been selected based on their ambition, visionary spirit and the demonstrable positive impact that their project has had on patient and staff experiences within the health and/or social care sector.?
16 November 2020
Six thousand UK volunteers will from today (Monday 16 November) be called upon to join another leading phase three Covid-19 vaccine study, as researchers around the world continue to work to secure a range of vaccines to help tackle coronavirus.
13 November 2020
A new clinical research study which is expected to start recruiting in January 2021, will use a novel approach based entirely at GP surgeries.
07 October 2020
Local health leaders and researchers are appealing for people with typical Covid-19 symptoms to take part in the community-based clinical trial called PRINCIPLE, joining the 1,000 people nationwide who have already signed up.
25 September 2020
More than 250,000 people in the UK have now volunteered to take part in COVID-19 vaccine studies through the NHS Vaccines Registry, over 17,000 of whom are in the West Midlands
02 September 2020
Patients, NHS trusts and local research teams across the region have contributed important data to new global research which shows that corticosteroids can significantly improve outcomes for severely ill patients with COVID-19.